![Jean Bennett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean Bennett
Directeur/Bestuurslid bij
Retinal Degeneration Fund
Profiel
Jean Bennett is the founder of Gensight Biologics SA (founded in 2012), Spark Therapeutics, Inc. (founded in 2013), Limelight Bio, Inc. (founded in 2017), and Opus Genetics, Inc. (founded in 2021).
She is currently the Director at Retinal Degeneration Fund since 2022.
Dr. Bennett holds a doctorate degree from Harvard University and the University of California, Berkeley.
Actieve functies van Jean Bennett
| Bedrijven | Functie | Begin |
|---|---|---|
Retinal Degeneration Fund
 Retinal Degeneration Fund Investment Trusts/Mutual FundsMiscellaneous Operates as a fund focuses on making mission-related investments in companies with projects nearing clinical testing | Directeur/Bestuurslid | 21-07-2022 |
Eerdere bekende functies van Jean Bennett
| Bedrijven | Functie | Einde |
|---|---|---|
Opus Genetics, Inc.
 Opus Genetics, Inc. BiotechnologyHealth Technology Provides clinical stage gene therapies for inherited retinal diseases | Oprichter | - |
| SPARK THERAPEUTICS, INC. | Oprichter | - |
Limelight Bio, Inc.
 Limelight Bio, Inc. BiotechnologyHealth Technology Develops genetic therapies | Oprichter | - |
| GENSIGHT BIOLOGICS S.A. | Oprichter | - |
Opleiding van Jean Bennett
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
9
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gensight Biologics SA
 Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases | Health Technology |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Limelight Bio, Inc.
Limelight Bio, Inc. BiotechnologyHealth Technology Develops genetic therapies | Health Technology |
Retinal Degeneration Fund
Retinal Degeneration Fund Investment Trusts/Mutual FundsMiscellaneous Operates as a fund focuses on making mission-related investments in companies with projects nearing clinical testing | Miscellaneous |
Opus Genetics, Inc.
Opus Genetics, Inc. BiotechnologyHealth Technology Provides clinical stage gene therapies for inherited retinal diseases | Health Technology |
